Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Nicotine-Eating Bacteria May Lead To New Anti-Smoking Drug, The Scripps Research Institute Study

Written by: | news@biospace.com | Dated: Sunday, August 9th, 2015

Although there is still a way to go, a team working on a new type of anti-smoking therapy based on a bacterial enzyme that devours nicotine before it can reach the brain are hopeful of success. In the Journal of the American Chemical Society, scientists from The Scripps Research Institute (TSRI) in La Jolla, CA, report how the enzyme can be made in the lab and has a number of features that make it a promising candidate for drug development.

Hey, check out all the research scientist jobs. Post your resume today!

 


Source: BioSpace Featured Stories

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom